Norbert Barlicki Memorial Teaching Hospital
- Address
- ul. Kopcinskiego 22, 90-153 Lodz, Poland
Norbert Barlicki Memorial Teaching Hospital - Nephrology Research
Norbert Barlicki Memorial Teaching Hospital is actively engaged in advancing therapeutic interventions for patients suffering from complications of chronic kidney disease. The center demonstrates particular expertise in addressing debilitating symptoms associated with renal conditions, contributing valuable clinical data to the development of novel treatment modalities.
- Chronic Kidney Disease-associated Pruritus (CKD-aP) management and treatment
- Dermatological manifestations of renal disease
- Quality of life improvements for dialysis and chronic kidney disease patients
The hospital's research program focuses on chronic kidney disease-associated pruritus, a condition that significantly impacts patient wellbeing and quality of life. Through participation in randomized, double-blind clinical trials, the center evaluates innovative topical therapies designed to provide relief for patients experiencing CKD-associated pruritus. This specialized research contributes to expanding treatment options for a condition that affects a substantial proportion of the chronic kidney disease population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Mc2 Therapeutics Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Mc2 Therapeutics Limited2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Norbert Barlicki Memorial Teaching Hospital
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Subjects with Chronic Kidney Disease-associated Pruritus (CKD-aP) | Mc2 Therapeutics Limited | Phase II | Not Recruiting | Feb 2023 | Feb 2024 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alanyl Glutamine | 1 | Unknown | 2023-02-20 | 2023-02-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.